| BC patients | Percentage |
---|---|---|
Age | ≥ 40 | 48% |
< 40 | 52% | |
Grade | I | 8% |
II | 64% | |
III | 28% | |
Histological type | Ductal | 92% |
Lobular | 28% | |
Molecular subtype | Luminal A | 52% |
Luminal B | 12% | |
HER2 enriched | 8% | |
TNBC | 28% | |
ER status | Positive | 64% |
Negative | 36% | |
PR status | Positive | 56% |
Negative | 44% | |
HER-2 status | Positive | 16% |
Negative | 84% | |
Lymphatic involvement | Yes | 60% |
No | 40% | |
Proliferative index (Ki-67) | High (> 14%) | 80% |
Low (< 14%) | 20% |